rs6351

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001044.5(SLC6A3):​c.162C>T​(p.Pro54Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,614,186 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P54P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0064 ( 6 hom., cov: 33)
Exomes 𝑓: 0.011 ( 105 hom. )

Consequence

SLC6A3
NM_001044.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.268

Publications

9 publications found
Variant links:
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
SLC6A3 Gene-Disease associations (from GenCC):
  • classic dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • SLC6A3-related dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • parkinsonism-dystonia, infantile
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-1443036-G-A is Benign according to our data. Variant chr5-1443036-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 470636.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.268 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00638 (971/152296) while in subpopulation NFE AF = 0.0109 (742/68012). AF 95% confidence interval is 0.0103. There are 6 homozygotes in GnomAd4. There are 455 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A3NM_001044.5 linkc.162C>T p.Pro54Pro synonymous_variant Exon 2 of 15 ENST00000270349.12 NP_001035.1 Q01959

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A3ENST00000270349.12 linkc.162C>T p.Pro54Pro synonymous_variant Exon 2 of 15 1 NM_001044.5 ENSP00000270349.9 Q01959
SLC6A3ENST00000713696.1 linkc.162C>T p.Pro54Pro synonymous_variant Exon 2 of 15 ENSP00000519000.1
SLC6A3ENST00000713698.1 linkc.162C>T p.Pro54Pro synonymous_variant Exon 2 of 5 ENSP00000519002.1
SLC6A3ENST00000713697.1 linkn.162C>T non_coding_transcript_exon_variant Exon 2 of 11 ENSP00000519001.1

Frequencies

GnomAD3 genomes
AF:
0.00639
AC:
972
AN:
152178
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00399
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.000579
Gnomad SAS
AF:
0.00786
Gnomad FIN
AF:
0.00301
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0109
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.00704
AC:
1769
AN:
251378
AF XY:
0.00761
show subpopulations
Gnomad AFR exome
AF:
0.00234
Gnomad AMR exome
AF:
0.00298
Gnomad ASJ exome
AF:
0.00169
Gnomad EAS exome
AF:
0.00103
Gnomad FIN exome
AF:
0.00333
Gnomad NFE exome
AF:
0.0107
Gnomad OTH exome
AF:
0.00587
GnomAD4 exome
AF:
0.0107
AC:
15663
AN:
1461890
Hom.:
105
Cov.:
33
AF XY:
0.0107
AC XY:
7772
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.00122
AC:
41
AN:
33480
American (AMR)
AF:
0.00356
AC:
159
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00176
AC:
46
AN:
26136
East Asian (EAS)
AF:
0.00262
AC:
104
AN:
39700
South Asian (SAS)
AF:
0.00988
AC:
852
AN:
86258
European-Finnish (FIN)
AF:
0.00477
AC:
255
AN:
53418
Middle Eastern (MID)
AF:
0.00381
AC:
22
AN:
5768
European-Non Finnish (NFE)
AF:
0.0122
AC:
13610
AN:
1112010
Other (OTH)
AF:
0.00950
AC:
574
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
974
1948
2921
3895
4869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00638
AC:
971
AN:
152296
Hom.:
6
Cov.:
33
AF XY:
0.00611
AC XY:
455
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00192
AC:
80
AN:
41562
American (AMR)
AF:
0.00399
AC:
61
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5170
South Asian (SAS)
AF:
0.00766
AC:
37
AN:
4832
European-Finnish (FIN)
AF:
0.00301
AC:
32
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0109
AC:
742
AN:
68012
Other (OTH)
AF:
0.00520
AC:
11
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
46
93
139
186
232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00818
Hom.:
8
Bravo
AF:
0.00656
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.0104
EpiControl
AF:
0.0102

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC6A3: BP4, BP7, BS1, BS2 -

Oct 05, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Classic dopamine transporter deficiency syndrome Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Parkinsonism-dystonia, infantile Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.1
DANN
Benign
0.59
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6351; hg19: chr5-1443151; API